MacroGenics, Inc. (MGNX) vs Nautilus Biotechnolgy, Inc. (NAUT)
A side-by-side comparison of MacroGenics, Inc. and Nautilus Biotechnolgy, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
MGNX
MacroGenics, Inc.
$3.72HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
NAUT
Nautilus Biotechnolgy, Inc.
$1.94HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
Total return — MGNX vs NAUT
growth of $100 · dividends reinvested · last 6yMGNX -86.1% (-28.0%/yr)NAUT -82.1% (-24.9%/yr)NAUT compounded faster over this window
MGNX NAUT
MGNX vs NAUT: by the numbers
- •NAUT is the larger company ($247M vs $236M market cap).
- •Both run net losses; MGNX's is the smaller (-8.70% vs -29747.89% net margin).
Metrics side by side
Valuation
| Metric | MGNX | NAUT |
|---|---|---|
| P/S ratio | 1.41 | 1299.34 |
| P/B ratio | 5.51 | 1.88 |
Profitability
| Metric | MGNX | NAUT |
|---|---|---|
| Gross margin | 71.12% | 0.00% |
| Operating margin | -48.72% | 0.00% |
| Net margin | -8.70% | -29747.89% |
| ROE | -34.04% | -43.11% |
| ROIC | -16.87% | -40.52% |
Growth (annualized)
| Metric | MGNX | NAUT |
|---|---|---|
| Revenue CAGR (5Y) | 7.33% | N/A |
| Total return CAGR (5Y) | -28.42% | -20.56% |
Frequently asked
- How have MGNX and NAUT total returns compared?
- Over the past 5 years, MGNX delivered -28.42% and NAUT delivered -20.56% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.